# Edesa Biotech, Inc.: Form 8-K, filed Aug 20, 2026

- Company: [Edesa Biotech, Inc.](/companies/edsa.md) (CIK 1540159)
- Form: 8-K
- Filed: 2026-08-20
- Accepted by EDGAR: Aug 20, 2026, 16:15 ET
- Period: 2026-08-19
- Accession: 0001171843-26-005686
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1540159/000117184326005686/f8k_081726.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1540159/000117184326005686/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1540159/000117184326005686/f8k_081726.htm

Filed Aug 20, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-005686. Last ingested by Listed: Oct 29, 2026, 17:02 ET. No prices; not investment advice.